EUVIMEDEUVIMED entdecken
Übersichtsarbeit

CD44: a stemness driver, regulator, and marker—all in one?

Steffen J Sonnentag, Nagwa S M Ibrahim, Veronique Orian-Rousseau iD

Stem Cells · 2024

DOI: 10.1093/stmcls/sxae060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cells, 2024. Verfasst von Steffen J Sonnentag und 2 weiteren Autor:innen. Beteiligte Einrichtung: Karlsruhe Institute of Technology, Institute of Biological and Chemical Systems-Functional Molecular Systems, Kaiserstraße 12, 76131 Karlsruhe, Germa…. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Neoplastic Stem Cells, Biomarkers, Tumor. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, EU-H2020-MSCA-COFUND EURIdoc programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although the concept of cancer stem cells is still controversial, previous studies have shown that blood cancers, as well as specific types of solid cancers such as colorectal cancer, rely on stem cells during the onset of tumor growth and further tumor development. Moreover, resistance to therapeutic treatment in leukemias such as acute myeloid leukemia and in colorectal cancer can be attributed to a small population of cells with stemness properties known as minimal residual disease. In this review, we look back on the discovery of cancer stem cells and the contribution of the findings in blood cancer to a parallel discovery in solid cancers. We focus on CD44 as a stem cell marker, both in blood cancers and in several types of solid cancers, particularly of the gastrointestinal tract. This review highlights newly discovered molecular mechanisms of action of CD44 which indicate that CD44 has indeed a function in stemness, stem cell maintenance, and drug resistance. We attempt here to make the link between the functions of CD44 isoforms in stemness and their involvement in specific steps of tumor growth and metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronan ReceptorsNeoplastic Stem CellsBiomarkers, TumorHumansAnimalsNeoplasmsDrug Resistance, Neoplasm

Stichwörter der Autor:innen

CXCR4acute myelogenous leukemiaadhesion receptorsadult stem cellsbone marrowcancercolorectal stem cells

Substanzen

Hyaluronan ReceptorsBiomarkers, TumorCD44 protein, human

Autor:innen und Institutionen

  • Karlsruhe Institute of Technology, Institute of Biological and Chemical Systems-Functional Molecular Systems, Kaiserstraße 12, 76131 Karlsruhe, Germany.

ORCID-Profile: Veronique Orian-Rousseau

Förderung

  • Deutsche Forschungsgemeinschaft
  • EU-H2020-MSCA-COFUND EURIdoc programme

Zitieren

APA

Sonnentag, S. J., Ibrahim, N. S. M., & Orian-Rousseau, V. (2024). CD44: a stemness driver, regulator, and marker—all in one?. Stem Cells. https://doi.org/10.1093/stmcls/sxae060

Vancouver

Sonnentag SJ, Ibrahim NSM, Orian-Rousseau V. CD44: a stemness driver, regulator, and marker—all in one?. Stem Cells. 2024. doi:10.1093/stmcls/sxae060

BibTeX
@article{Sonnentag2024,
  author = {Sonnentag, Steffen J and Ibrahim, Nagwa S M and Orian-Rousseau, Veronique},
  title = {CD44: a stemness driver, regulator, and marker—all in one?},
  journal = {Stem Cells},
  year = {2024},
  doi = {10.1093/stmcls/sxae060}
}
Kostenlos starten →